Company News: Page (1) of 1 - 02/28/12 Email this story to a friend. email article Print this page (Article printing at page facebook

DIAGNOS Announces Grant of Stock Options

(February 28, 2012)

BROSSARD, QUEBEC, CANADA -- (Marketwire) -- 02/28/12 -- DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces that, on February 27, 2012, the Board of Directors has approved a grant of 90,000 stock options to three officers of the Corporation under the terms of the stock option plan of the Corporation approved by the Shareholders in September 2008.

The exercise price of these options has been established at C$0.26 per share. Grants of stock options vest at the rate of 33.33% per year, commencing with the first anniversary of the grant. The expiry date to which these options can be exercised has been fixed to February 26, 2017.


Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.

For further information, please visit our website at or the SEDAR website at

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Andre Larente, President
(450) 678-8882

Louis Morin
Bid Capital Markets
(514) 845-1101

Copyright @ Marketwire

Page: 1

Related Keywords: Diagnos Inc. , Canada, Marketwire, Inc., , Computer Science, Entertainment,

Content-type: text/html  Rss  Add to Google Reader or
Homepage    Add to My AOL  Add to Excite MIX  Subscribe in
NewsGator Online 
Real-Time - what users are saying - Right Now!

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved